Andrea Skelton, MD
Psychiatry · Tulsa, OKNPI 1003131285
Payments from drug & device makers
Across 13 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$82
- Johnson & Johnson$53
- AbbVie$37
- Neurocrine Biosciences, Inc.$37
- Indivior Inc.$37
- Otsuka America Pharmaceutical, Inc.$34
- plus $17 from 1 others
What the payments were for
- Food & beverage$298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $82 |
| Johnson & Johnson | 3 | $53 |
| AbbVie | 2 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| Indivior Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
How this compares
$298 in reported general payments places this provider in the 50th percentile of 328 psychiatry providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 88 | $7,408 |
| EliquisApixaban | 13 | $7,141 |
| Naltrexone Hcl | 37 | $1,331 |
| Doxepin Hcl | 90 | $1,092 |
| Oxcarbazepine | 29 | $1,050 |
| Atomoxetine Hcl | 12 | $872 |
| Quetiapine Fumarate | 51 | $433 |
| Gabapentin | 43 | $414 |
| Bupropion Hcl SrBupropion Hcl | 53 | $414 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $402 |
| Ibuprofen | 30 | $369 |
| Omeprazole | 40 | $303 |
| Trazodone Hcl | 76 | $259 |
| Buspirone Hcl | 29 | $250 |
| Hydroxyzine Pamoate | 20 | $182 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Tulsa
- Sarah LandTulsa$2.8M
- Ondria GleasonTulsa$68K
- Martin PaulusTulsa$66K
- Jeffrey CatesTulsa$48K
- Bradley McClureTulsa$15K
- Katrina CraderTulsa$15K
- Kaitlin CoresTulsa$10K
- Charles van TuylTulsa$9K
- Michael DubriwnyTulsa$8K
- Joe SpeerTulsa$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.